Dr Tara Sutherland
Location: Room 309, Ashworth Laboratories
Phone: 0131 651 3630
Email: tara.sutherland@ed.ac.uk
Website: http://zeldia.cap.ed.ac.uk/allenlab/people/sutherland.htm
CV
- 2007-current: Postdoctoral Fellow in the Allen Lab, Institute of Immunology and Infection Research (3IR), University of Edinburgh: “Role of chitinases in allergy induced inflammation in the lung”
- 2006: Post doctoral position - Drug Discovery Biology Lab, Department of Pharmacology, Monash University, Victoria, Australia.
- 2002 - 2006: Research Assistant (part-time) - Cryptopharma, Immunopharmacology Lab, University of Melbourne, Australia.
- 2002 - 2005: PhD - ImmunoPharmacology Lab, Department of Pharmacology, University of Melbourne, Australia
- 1997 - 2001: BSc (Hons) University of Melbourne
Publications
- Sutherland TE, Schuliga M, Harris T, Eckhardt BL, Anderson RL, Quan L and Stewart AG
- 2-methoxyestradiol is an estrogen receptor agonist that supports tumor growth in murine xenograft models of breast cancer. (2005) Clin Can Res. 11(5):1722-32.
- Stewart AG, Sutherland TE, Schuliga M, Harris T, Quan L, McAllister D, Pool B, Eckhardt B, Anderson RL
- The potential and suitability of 2-methoxyestradiol in cancer therapy: Author Reply (2005) Clin Can Res 11(16): 6094-5
- Langenbach SY, Wheaton BJ, Fernandes DJ, Jones C, Sutherland TE, Wraith BC, Harris T, Schuliga M, McLean C, Stewart AG .
- Glucocotricoid- and 2-methoxyestradiol- resistant fibrogenic responses in Bleomcin-induced lung fibrosis in mice. (2007) Can J Physiol Pharm
- Sutherland TE, M Schuliga, RL Anderson, RA Hughes, J Ziogas and AG Stewart.
- 2-Methoxyestradiol - a unique blend of activities generates a new class of anti-tumour/anti-inflammatory agents. (2007) Drug Discovery Today. Invited Review